Category - Executive Moves

Executive Moves

ObsEva names Brian O’Callaghan as CEO

ObsEva (NASDAQ:OBSV) appointed Brian O’Callaghan as CEO, effective Dec. 1. He succeeds ObsEva’s co-founder, Ernest Loumaye, M.D., Ph.D., who is retiring from his role as CEO but will remain a director of the company. Mr...

November 9, 2020

Executive Moves

Marizyme names Neil Campbell as president and CEO

Marizyme (NASDAQ:MRZM) appointed Neil Campbell, Ph.D., as CEO, replacing executive chairman James Sapirstein, who has been the company’s interim CEO since September 2020. Dr. Campbell currently serves as chairman of...

November 6, 2020

Executive Moves

LogicBio names Mariana Nacht as CSO; Kyle Chiang as COO

LogicBio Therapeutics (NASDAQ:LOGC) appointed Mariana Nacht, Ph.D., as CSO, effective Nov. 30; and promoted Kyle Chiang, Ph.D., to the role of COO, effective Nov. 2. The company is expanding its leadership team to...

November 3, 2020

Executive Moves

Aethlon Medical names Charles Fisher as CEO

Aethlon Medical (NASDAQ:AEMD) appointed Charles Fisher, M.D., as CEO, effective Oct. 30. Dr. Fisher joined Aethlon as a member of its board and served as its chairman since November 2017. He succeeds Dr. Timothy Rodell...

November 3, 2020

Executive Moves

iBio appoints global biotech operations expert, Randy Maddux, as COO

iBio (NYSE AMERICAN:IBIO) appointed biotech industry veteran, Randy Maddux, as COO, effective Dec. 1. Mr. Maddux has more than 20 years of global biologics drug development and manufacturing, business development and...

November 3, 2020

Executive Moves

Soliton appoints Brad Hauser as president, CEO

Soliton (NASDAQ:SOLY) named Brad Hauser as president and CEO as the company prepares for its commercial launch. Mr. Hauser most recently was VP of R&D and general manager for CoolSculpting at Allergan Aesthetics, an...

November 2, 2020

Executive Moves

Fibrocor names William Fanslow as SVP drug development

Closely-held Fibrocor Therapeutics appointed industry veteran, William Fanslow Ph.D., as SVP of drug development. Dr. Fanslow has more than 20 years of experience in drug development, including both small molecules and...

October 26, 2020

Executive Moves

Perimeter Medical Imaging AI names Jeremy Sobotta as CEO; Tom Boon as COO

Perimeter Medical Imaging AI (TSXV:PINK; FSE:4PC) appointed Jeremy Sobotta as its new CEO and Tom Boon as its new COO, effective immediately. Mr. Sobotta was most recently Perimeter’s CFO and replaces Tom Boon as CEO...

October 22, 2020

Executive Moves

iBio appoints accomplished financial executive, Gary Sender, to board

iBio (NYSE AMERICAN:IBIO) appointed senior financial executive, Gary Sender, as a director and a member of the board’s compensation committee. In addition, Mr. Sender was appointed chair of iBio’s audit committee...

October 15, 2020

Executive Moves

iBio appoints senior biopharma executive, Dr. Alexandra Kropotova, to board

iBio (NYSE AMERICAN:IBIO) appointed senior biopharma executive, Dr. Alexandra Kropotova, as a director and a member of the board’s new science and technology committee. Dr. Kropotova has expertise in all phases of...

October 15, 2020

Category - Executive Moves

ObsEva names Brian O’Callaghan as CEO

Marizyme names Neil Campbell as president and CEO

LogicBio names Mariana Nacht as CSO; Kyle Chiang as COO

Aethlon Medical names Charles Fisher as CEO

iBio appoints global biotech operations expert, Randy Maddux, as COO

Soliton appoints Brad Hauser as president, CEO

Fibrocor names William Fanslow as SVP drug development

Perimeter Medical Imaging AI names Jeremy Sobotta as CEO; Tom Boon as COO

iBio appoints accomplished financial executive, Gary Sender, to board

iBio appoints senior biopharma executive, Dr. Alexandra Kropotova, to board

Follow Us

General

More

Sign up for the BioTuesdays weekly newsletter